| Names | |
|---|---|
| Preferred IUPAC name | 2-methyl-1,2-thiazol-3(2H)-one |
| Other names | 2-Methyl-3(2H)-isothiazolone 2-Methyl-4-isothiazolin-3-one 2-Methyl-4-isothiazoline-3-one MIT Proxel Nipacide 2-methylisothiazolone 2-methylisothiazolin-3-one |
| Pronunciation | /tuː ˈmɛθɪl fɔːr aɪˌsoʊθaɪəˈzoʊlɪn θriː oʊn/ |
| Identifiers | |
| CAS Number | 2682-20-4 |
| 3D model (JSmol) | ``` 4VHR ``` |
| Beilstein Reference | 1223642 |
| ChEBI | CHEBI:81923 |
| ChEMBL | CHEMBL3091326 |
| ChemSpider | 56453 |
| DrugBank | DB14016 |
| ECHA InfoCard | 16a264e9-bfe3-428b-abb2-e9028b5bdbb8 |
| EC Number | 220-239-6 |
| Gmelin Reference | 83462 |
| KEGG | C18430 |
| MeSH | D000071243 |
| PubChem CID | 69796312 |
| RTECS number | GZ1250000 |
| UNII | GZP7N7XZ2S |
| UN number | UN3439 |
| Properties | |
| Chemical formula | C4H5NOS |
| Molar mass | 115.15 g/mol |
| Appearance | colorless to yellowish transparent liquid |
| Odor | Characteristic |
| Density | 1.02 g/mL at 25 °C |
| Solubility in water | Soluble |
| log P | 0.486 |
| Vapor pressure | 0.62 Pa (25 °C) |
| Acidity (pKa) | 8.0 |
| Basicity (pKb) | 5.6 |
| Magnetic susceptibility (χ) | -23.34·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.407 |
| Viscosity | 10 mPa·s (25℃) |
| Dipole moment | 3.98 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 175.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -242.6 kJ·mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -386.8 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | D08AJ59 |
| Hazards | |
| GHS labelling | GHS02, GHS05, GHS07, GHS09 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H318, H315, H317, H301, H400, H410 |
| Precautionary statements | P261, P273, P280, P302+P352, P305+P351+P338, P333+P313, P337+P313, P362+P364 |
| NFPA 704 (fire diamond) | 2-3-2-W |
| Flash point | > 96°C |
| Autoignition temperature | 215°C |
| Lethal dose or concentration | LD50 (rat, oral): 232 mg/kg |
| LD50 (median dose) | LD50 (median dose): 232 mg/kg (rat, oral) |
| PEL (Permissible) | 0.2 mg/m³ |
| REL (Recommended) | 15 μg/g |
| IDLH (Immediate danger) | Not established |
| Property | Technical Commentary |
|---|---|
| Product Name & IUPAC Name |
2-Methyl-4-Isothiazolin-3-One The IUPAC name is 2-methyl-1,2-thiazol-3(2H)-one. This identity is assigned at the synthesis stage and does not change through isolation or formulation. Naming conventions in quality documentation follow IUPAC rules when registering regulatory dossiers and batch certificates. |
| Chemical Formula |
C4H5NOS The molecular formula directly follows from the controlled raw material conversion. Variations in process water or reagent grade do not alter the empirical formula. Quantitative NMR and elemental analysis allow batch verification at the release stage. |
| Synonyms & Trade Names | Common synonyms include MIT, Methylisothiazolinone, and 2-Methyl-4-isothiazolin-3-one. Trade names follow commercial strategy, but chemical identification remains consistent on COA, MSDS, and shipment documentation. |
| HS Code & Customs Classification | The HS Code assigned in most jurisdictions for this product is typically 2934.99 (heterocyclic compounds, without oxygen hetero-atom(s) only, not elsewhere specified). Customs authorities may require additional codes depending on downstream application (biocidal, industrial, intermediate). For international shipments, technical documentation includes the declared code and clarifies the intended end use, as this compounds' classification impacts customs inspection and auditing for antimicrobial or preservative use. |
Every identifier in the table above links to steps in industrial production and quality control workflow. The IUPAC name tracks product lineage in legal and regulatory submissions. The molecular formula ensures analytical methods, such as chromatography and titration, are traceable to the substance’ core atomic arrangement, unaffected by downstream formulation grade. Trade names assist in technical support, while regulatory classification in the HS system affects inspection on export and insurance during transit.
Selection of raw materials impacts impurity profile and, by extension, how the chemical is classified during customs clearance. For MIT, route- and grade-specific documents may be required for shipments destined for applications regulated under biocidal or cosmetic laws. Production departments document the specific trade name or code to match customer contracts, but always refer back to the IUPAC root and formula for batch traceability and dispute resolution.
From the manufacturer's viewpoint, correct assignment of chemical identifiers and customs code is not purely clerical. Inaccurate declarations can disrupt batch clearance at border checkpoints, increase regulatory scrutiny, or trigger re-testing at external facilities. Process and quality teams maintain strict harmonization between electronic batch records (EBR), regulatory filings, and shipping paperwork, referencing CAS and formula as immutable anchors of the product's industrial identity.
MIT in pure form often presents as a white to light yellow crystalline solid. Intermediate grades produced for industrial liquid formulations, such as biocide concentrates, may yield a colorless to pale yellow solution, with a faint characteristic odor that grows detectable at higher concentrations. Crystallization and solution appearance tend to shift with purity, water content, and intended use—higher purity MIT solidifies at a lower melting point, whereas technical grades show visual impurities that are process- and raw material dependent.
Exact melting and boiling points vary depending on water inclusion and grade but generally align with reference values seen across the chemical industry. Density figures for solid or concentrated solution correlate closely with solution strength, presence of stabilizers, and impurities, which are controlled as per the intended application—biocides, preservatives, or intermediates for further synthesis.
MIT demonstrates reactivity towards nucleophiles, particularly in alkaline or highly reducing environments. These features require close monitoring during bulk formulation, especially for in-can preservation where pH and reducing agents modulate MIT stability over time. Compatibility with formulation components should always be confirmed at the intended use level, as unintended complexation or hydrolysis affects both active content and downstream effectiveness. Grade and application influence the degree of chemical stability required—industrial biocides demand longer shelf stability under shipment and storage temperatures compared to synthesis intermediates processed in dedicated production cycles.
MIT exhibits good solubility in water and certain alcohols. For aqueous biocidal formulations, controlled temperature and dilution methods avoid precipitation and maintain clarity. Feed water mineral content impacts dissolution efficiency, a variable tracked during both plant-scale and laboratory-scale blending. Highly purified water is generally preferred to reduce side reactions during storage.
Specification tables typically reflect requirements specific to market segment and customer application such as industrial sanitizers, paint preservatives, or cosmetic microbial control. Typical specification items for MIT include assay (active content, expressed as %), color (APHA or Hazen units), pH for solutions, and moisture content. Other parameters—such as chloride, sulfate, or residual starting material profile—are set relative to the criticality for the end use. Detailed specifications are set by grade and by contractual requirement.
Impurity profiles arise from both raw material quality and synthesis byproducts. The most relevant impurities in MIT include unreacted precursors, sulfur-containing side-products, and hydrolysis degradation compounds. These are kept within specified maximum levels that are grade-specific or defined according to region-specific regulatory acceptance. Purity demands for high-end applications in paints and personal care exceed those for industrial water treatment.
Routine analysis includes high-performance liquid chromatography for active MIT content, titrimetric or spectroscopic determination for impurities, and visual or instrumental methods for color. For some qualities, in-house developed methods are benchmarked to internal standards or to internationally recognized compendia, as required by customers or regulators. Batch release depends on meeting the complete panel of agreed-upon tests, with final release governed by internal quality management protocols and customer validation.
The production of MIT draws on select sulfur, amine, and methylating agent streams. The raw material quality and supply reliability directly impact final product purity and process efficiency. Alternative grades are sourced depending on target cost structures and customer use. Suppliers are evaluated for impurity load, trace metal content, and water content, which all factor into downstream purification demands.
Synthesis most commonly applies direct cyclization of methylthioamide precursors under oxidizing conditions. Route selection reflects a compromise between yield, impurity burden, and waste minimization. The chemistry involves controlled introduction of oxidant and maintenance of tightly defined conditions to favor ring closure and limit over-oxidation, with reaction medium and temperature dictating selectivity and rate.
Key control points include raw material feed rates, temperature hold times, and exact oxidant addition sequencing. Impurity removal, whether by liquid-liquid extraction, crystallization, or adsorptive treatment, is tailored to the impurity spectrum typical of the synthesis route in use. Recycle streams, intermediate storage, and final batch pooling are all monitored for batch-to-batch consistency, with additional purification steps applied for higher-grade requirements.
Batch release relies on multiple quality gates, including starting material traceability, critical in-process control points for key characteristics, and finished product analysis. Out-of-spec material is either reprocessed or downgraded, with all deviations logged and evaluated for root cause. Quality assurance aligns with both customer-driven requirements and internal standards reflecting years of production experience.
MIT’s thiazolinone ring readily undergoes substitution and addition reactions under nucleophilic attack. Industrial users exploit these properties for both biocidal action and chemical modification. Reaction conditions and catalysts depend on the desired derivative—mild alkaline conditions promote ring opening, while strong nucleophiles or reducing agents target the sulfur atom.
Temperature, pH, and solvent choice drive selectivity in MIT-based reactions, and these factors are tightly controlled in both the main plant and laboratory settings during scale-up development. Downstream modifications to produce tailored preservatives or intermediates use MIT as a reactive building block, with all safety and environmental aspects rigorously assessed in advance.
Major derivatives include blended isothiazolinone formulations and specialties for coatings or metalworking. The capacity to generate a narrow impurity profile makes MIT a preferred option in fine chemical synthesis streams. Each downstream product sets expectations on the input grade, with upstream process adaptation as a recurring necessity.
Container type, ambient temperature, and humidity have direct effects on MIT stability and user safety. Opaque and corrosion-resistant containers, either high-grade polyethylene or lined drums, suit both plant storage and external shipment. Shelf life for MIT varies by concentration and presence of stabilizer: higher-purity MIT in sealed systems generally surpasses that of technical blends exposed to air or light. Routine monitoring for odor change, discoloration, or precipitate serves as a practical quality safeguard.
Polymer compatibility tests indicate that MIT at high concentrations can degrade certain plastics and elastomers over extended contact. Material of construction must be validated for compatibility over expected storage duration and under accidental contact conditions. Metal containers with specific linings are used, as unlined carbon steel risks corrosion or product decomposition.
MIT degradation manifests through yellowing, viscosity changes in solutions, and decreasing assay values. Regular retesting of inventory is practiced, especially for material held under sub-optimal conditions, with out-of-spec material segregated or reprocessed as dictated by internal procedures and product stewardship commitments.
Classification aligns with regulatory frameworks governing acute and chronic toxicity, skin sensitization, and aquatic toxicity. Appropriate hazard and precautionary statements are updated with reference to current regulatory guidance and product-specific testing data.
Occupational safety documentation highlights the irritant and sensitizer potential of MIT, and these statements are prominent in both plant and shipment documentation. Operators receive targeted safety training based on actual exposure risks encountered in production and packaging, which accounts for both airborne and skin contact routes. Industrial hygiene practice mandates appropriate personal protective equipment during all handling stages.
Data on MIT’s toxicity profile draws from long-standing in-house testing and public literature, with workplace exposure control informed by both regulatory and internal occupational health standards. Airborne monitoring is implemented at critical plant points, especially during open handling or reaction charging operations. Engineering controls such as local extraction, complemented by personal monitoring, are prioritized. Specific local exposure limits are followed as mandated by jurisdiction, with documentation supplied to end users according to contract or customer request.
Production levels for MIT rely on the selected process route and access to intermediate isothiazolinone compounds. Batch capacity tracks closely with reactor size and campaign allocation because MIT shares upstream capacity with other isothiazolinone products. Chronic shortages or surpluses stem from sudden demand in household or industrial preservation, unplanned shutdowns, or upstream bottlenecks in raw materials such as methyl-thiazole feedstocks. Domestic manufacturing lines dedicate separate filtration and purification stages for various grades. Actual availability depends on the end-use grade: preservative, biocidal, or intermediate. Orders above regular stock levels often require dedicated campaign runs and negotiation on allowable specifications and impurity profile.
MOQ varies by grade and packaging. High-purity application can require smaller runs with tighter in-process controls, often booked on a campaign basis, leading to 3–6 weeks lead time for nonstandard volumes or special packaging. Bulk industrial-grade MIT is usually supported from rolling stock, with shorter lead times for standard orders and flexibly adjusted for customer-specified purity or packaging. Unexpected process upsets, especially in critical impurities (such as sulfide variants), prolong lead times due to the batch reprocessing requirement after quality deviation.
Packing format and size hinge on end-use and volatility control. Manufacturers supply MIT in standard IBCs, HDPE drums, and, for higher purity applications, fluorinated containers or lined drums to suppress decomposition and maintain batch identity. Specific certification (food, cosmetic, or industrial biocidal) dictates eligibility for certain packaging materials and influences quality assurance chain-of-custody documentation.
Transportation typically follows hazardous goods requirements, varying by active concentration and destination region. Exported shipments need extra compliance steps for regulated markets like the EU or US, resulting in longer customs clearance and higher documentation costs. Standard contract terms settle on LC at sight for high-volume buyers, while TT in advance is more common with small-lot customers or in volatile price climates.
Raw material pricing revolves around the cost of methyl-thiazole or related sulfur-containing intermediates. Upstream volatility can result from short-term sulfur price surges, shutdowns of key intermediates, or export restraints in feedstock-producing regions. Cost structure analysis includes energy input, the yield efficiency at each reaction stage, and waste treatment demands due to evolving environmental controls. Periodic price shocks trace back to environmental inspections or regulatory changes in major upstream chemical parks in China or India, where most global supply originates. Raw material contracts frequently tie to multi-month spot benchmarks, shifting costs for each production run.
Product pricing stratifies along grade (industrial vs cosmetic vs preservative), purity requirements, and the necessity of regulatory certifications. Higher purity grades routinely require multi-step recrystallization and advanced analytical certification, resulting in extra variable cost and frequency of batch rejection. Certifications for food or non-leaching packaging involve extra validation steps, driving a price gap versus technical grades. Compliance verification in regulated markets can trigger significant cost differentials based on required test scope and batch traceability documentation.
Worldwide demand for MIT correlates with regulations on formaldehyde alternatives, growing heavily in household, personal care, and industrial preservation. Major upstream supply comes from East Asia, with production clustered in a limited number of integrated chemical complexes. Downstream applications in Europe and North America lean heavily on certified imports, given the regulatory environment and local production scale.
United States and European Union import large volumes, demanding proven compliance with biocidal and REACH regulations. Japan and India source both domestically and via imports, with focus on application purity for consumer products. China dominates primary synthesis, with local markets absorbing technical grade volumes and export flows geared toward both emerging and mature regulatory markets. Supply shocks or trade disputes in these regions sharply affect delivered cost and availability for end users globally.
Ongoing tightening of environmental regulations in production zones will push up direct and indirect manufacturing costs. Input price volatility in sulfur and methyl-thiazole derivatives is expected to persist due to capacity concentration and periodic plant maintenance schedules. End-user price pressure from regulatory-driven demand and global logistics disruptions may contribute to price upswings. Long-term price guidance hinges on regional policy changes (ban on parabens, microbicides), anti-dumping duties, and the emergence of validated green process routes. Substitution effects and consumer trends toward “clean-label” products also shape 2026 price forecasts, with a continuing premium for certified, low-impurity grades.
Price and demand trend analysis draws from internal sales data, market feedback, procurement pricing benchmarks, import/export clearance documentation, and industry association bulletins. Compliance and regulatory status monitored through direct contact with regional authorities, third-party audit records, and recall bulletins.
Recent years have seen several production site upgrades and expansions, with a noticeable shift toward closed-system operations and enhanced impurity tracking capabilities. A handful of significant plant shutdowns in East Asia have caused brief but sharp increases in spot market prices. International logistics disruptions, particularly container shortages, occasionally delay deliveries to key segments. Mergers or supplier consolidation events have also altered sourcing patterns for large-scale users.
Key global economies continue to revise allowable concentrations and end-use limitations for MIT, especially in cosmetic and personal care formulations. REACH updates regularly introduce new requirements for impurity profiling and batch traceability, resulting in amperage increases in control and documentation workload per shipment. Several countries, particularly in the EU and Latin America, require additional local notification or registration, creating a complex web of batch release criteria and application-specific restrictions.
Manufacturers implement process optimization to reduce impurity load and adopt more robust in-process analytical controls to address client audits and regulatory pressure. Supplier adaptation strategies include campaign-based production for sensitive grades, proactive risk evaluation of raw material sources, and investment in advanced packaging solutions that preserve product characteristics during extended storage and transit. Enhanced batch documentation routines and expanded technical support for downstream users form part of the ongoing compliance assurance strategy.
2-Methyl-4-Isothiazolin-3-One serves primarily as a microbicide and preservative in various formulations where microbial growth control is critical. On the production floor, selection of MIT grade reflects not only the intended application but also the processing tolerances and downstream regulatory environments. Manufacturers rely on MIT in the following sectors:
| Application | Typical Grade(s) Used | Key Specifications Considered | Notes on Selection |
|---|---|---|---|
| Industrial Water Treatment | Technical Grade | Assay, main impurities, solution clarity | Technical grade balances assay value with economic feasibility for high-volume dosing. |
| Paints, Coatings | Technical or Industrial Grade | Assay, color, residual solvent content | Color control and compatibility with organic binders influence final choice. |
| Cosmetics / Personal Care | Cosmetic or High-Purity Grade* | Assay, formaldehyde content, residual solvents | Product must comply with regional cosmetic regulations. Hazardous impurities must fall within safety thresholds. |
| Detergents / Household | Technical or Industrial Grade | Assay, odor profile, pH | Odor traceability and interaction with surfactants are batch-release criteria. |
*Cosmetic or high-purity material is only supplied against confirmation of regulatory compliance for the user’s target market.
Narrow down intended use: water treatment, coatings, cosmetic, cleaning, or industrial preservation. This decision shapes all further technical dialogue with the supplier. In production, process design and typical contaminant load drive which quality attributes take priority during internal release.
Each application faces distinct regulatory landscapes. Water treatment may impose specific biocidal approval pathways; personal care products face restrictions in many regions. Customers must clarify intended sales geography and application context before the manufacturer commits to a supply route. In the plant, regulatory review determines whether batch segregation or change control is needed.
Some end-users prioritize maximum assay and minimum impurities due to process sensitivities, market requirements, or downstream blending challenges. Batch variability in impurity levels can lead to product recalls or failed audits. Where such needs exist, sourcing from lines using higher purity raw materials or introducing additional purification may be required. Lower grade may suffice where users have compatible process controls or where downstream blending dilutes non-critical impurities below acceptance limits.
High-volume industrial users often tolerate wider specifications for economic efficiency, provided risk of downstream disturbance remains manageable. Paint and adhesive formulators may prefer intermediate grades for cost optimization if trace impurity or slight coloration poses no formulation issue. For specialty and regulated applications, procurement may restrict purchase to smaller lots subject to higher-level release testing and traceable production histories.
Each application reacts uniquely to source variation—shelf stability, formulation compatibility, and end-product performance require validation under simulated conditions. Plant labs generally identify batch-to-batch reactivity; formal sample qualification processes ensure that specification commitments translate to real-world conditions. Confirmation of sample provenance and batch record retention remains standard practice.
Production of 2-Methyl-4-Isothiazolin-3-One operates under audited quality management systems structured according to recognized international standards. Certification status typically reflects the specifics of each manufacturing site and regular full-scope audits focus on raw material traceability, in-process control, and batch record accountability. Established management protocols facilitate root-cause analysis, deviation documentation, and systematic corrective measures. This system strengthens both process integrity and consistency in final product release, supporting complex customer and regulatory audit requirements across different regions.
Compliance documentation for MIT aligns with application and market access requirements. For customers in regulated markets, specific supporting files include pesticide regulatory dossiers, preservatives efficacy data, and toxicology summary reports. In cases where MIT is destined for sensitive end-uses, specialized certifications apply, and these depend on the target industry and country of import. Copies of such files are available based on formal request and end-use declarations. This approach allows adaptation to both commodity and specialty application requirements.
Technical documentation is assembled according to product grade: standard industrial grades and high-purity variants carry their own batch release reports, impurity profile summaries, and safety data sheets. The extent and type of certification depend on the customer’s downstream validation standards and regional obligations. Comprehensive traceability is supported through retained samples, full batch record access, and direct engagement with end-user quality assurance teams during customer audits or change-control negotiations. Analytical results, process flow diagrams, and lot release criteria are provided in response to documented customer enquiries addressing impurity profiles and trace-level contaminants.
Sustaining reliable production of MIT depends on multi-line synthesis capacity and feedstock integration within the facility. Ongoing demand from both multi-ton and specialty segment buyers prompts scheduling that prioritizes both continuous and batch production modes. Long-term cooperation agreements benefit from fixed allocation and spot procurement flexibility, determined based on customer call-off patterns, buffer stock arrangements, and shipment scheduling. This ensures both high-volume and program-based buyers receive a consistent allocation, and priority production slots mitigate unplanned downtime risk.
The manufacturing workflow for MIT scales according to forecasted monthly requirements and seasonal demand swings observed in applications such as paints, adhesives, and personal care preservatives. Core synthesis capacity is backed by qualified intermediate stock and down-stream purification reserves, with redundancy built into critical process steps to avoid supply disruptions. Ongoing investments in process automation, utility controls, and preventive maintenance directly support stable year-round output. For contract customers, dedicated line assignment is available, subject to agreed volume commitments and technical requirements.
MIT samples ship under an established protocol where lot traceability, grade matching, and documented chain-of-custody are closely observed. Sample volumes correspond to intended laboratory or pilot trial scale and technical documentation accompanies each sample order, including analytical methods where required. Requests route directly through technical support, with direct feedback channels for user trial data and any investigational needs around impurity thresholds, formulation compatibilities, or end-use stability observations. Full sample history and any production deviations remain accessible for customer review.
Flexibility in procurement options addresses varying buyer strategies, including rolling forecast contracts, MOQ-splitting, and just-in-time delivery coordination. Structured call-off mechanisms permit adjustment of release quantities based on in-market fluctuations or unexpected project delays. Collaborations sometimes integrate dual-release programs or vendor-managed inventory by mutual agreement; this reduces the risk of obsolescence and streamlines inventory handling for complex manufacturing schedules. For customers facing custom regulatory documentation or shifting compliance thresholds, dedicated technical liaison teams manage adjustments quickly, including labeling revisions and region-specific documentation generation.
Research on 2-Methyl-4-Isothiazolin-3-One (MIT) today reflects pressure from regulatory bodies and downstream customers to reduce allergenic risks while maintaining reliable antimicrobial efficacy. In-house R&D teams focus efforts on adaptation to market trends such as low-release and low-residual preservation systems, especially in water-based formulations for coatings, adhesives, water treatment, and personal care. Technologists track shifts in permissible dosages across major markets, as allowable limits for isothiazolinones continue to tighten in several regions. Selection of stabilizers and co-preservatives for synergy with MIT represents an ongoing theme, as formulators seek to address both regulatory thresholds and performance challenges in complex matrices.
MIT’s role extends in sectors that require broad-spectrum microbial protection without the odor or volatility issues associated with other biocides. Our technical teams encounter increased inquiry for MIT’s fit in industrial air washers, ink manufacturing, and certain construction material additives, where bioburden pressures are high and commercial downtime due to spoilage is cost-prohibitive. Newer applications experiment with MIT at reduced concentrations, often in systems employing multi-modal biocidal strategies that combine MIT with less controversial preservatives. The function of MIT as a secondary preservative, rather than a standalone solution, grows with the pressure to comply with newer eco-labeling and sensitization guidelines.
Production challenges routinely trace to the purity required by downstream users, particularly for cosmetic and household products. The main technical bottleneck involves control of isothiazolone ring integrity through the synthesis and purification phases. This affects both color and odor in final formulations, as low-level by-products may cause yellowing or instability during storage. Technicians continuously optimize raw material feedstock and reaction conditions for each grade, updating process control parameters based on analytical feedback from both lab-scale and commercial lots. Breakthroughs recently include more efficient by-product removal steps and improved process analytics, yielding grades with reduced nitrosamine and halogenated impurities.
MIT’s demand patterns shift with the tightening of global preservative regulations. Over the next three to five years, volumes in traditional segments may plateau or contract in Europe and parts of North America due to stricter sensitization classification. Instead, strongest growth prospects arise in APAC and selected Latin American markets, where evolving product standards still accommodate MIT use at practical concentrations. Industrial and institutional preservation, where batch shelf lives are extended by technical agreement, provide continuing opportunity. Routine adjustments of manufacturing scale and formulation portfolio will be required to track market access and maximize efficiency in grade assignments for permitted regions and uses.
Manufacturers focus spend on process intensification steps that favor removal of trace impurities without sacrificing yield. Upgrades in analytical method development for nitrosamine detection, and closed-loop control of reaction pH and feed rates, support tighter specifications required by sensitive applications. New process routes under evaluation target lower energy input and reduced waste generation. Technical engagement with raw material suppliers to secure consistently high-purity starting streams remains essential in minimizing off-grade material risks. The ongoing evolution in MIT technology aims for deliverable grades with enhanced stability profiles, especially for longer-shelf life bulk preservative systems.
Shifts toward green chemistry shape decisions on process solvent selection, water management, and by-product reclamation. Gradual transition away from hazardous intermediates and legacy solvent systems aligns with worldwide calls for process sustainability. Internal initiatives prioritize closed-loop water usage and minimization of halogenated waste, aiming for a lower environmental load per unit of active MIT produced. Eco-toxicity metrics for effluent and airborne releases are tracked through routine EHS audits, with feedback used to refine batch operation settings. Progress on lifecycle analyses guides both product stewardship communication and future plant investments.
Process and application engineers provide direct consultation tailored to grade-specific requirements. Inquiries from customers routinely target topics such as formulation adjustment, shelf-life behavior under aggressive environmental exposure, or trace impurity management. Support covers adaptation to end-use legislation shifts, guidance for compliance with restricted substance lists, and technical input for on-site trouble-shooting if off-specification behavior arises. Response teams coordinate with QA and R&D to ensure solution paths align with measured batch values and documented production conditions.
Optimization programs include hands-on trials in customer-relevant matrices, leveraging in-house pilot facilities or collaborative test campaigns. Technicians help match MIT grades to specific physical and chemical context—examples include viscosity/pH impact studies, monitoring for possible interaction with formulation co-ingredients, or stress-testing preservative persistence in aggressive microbiological loads. Feedback from joint development projects cycles into product improvement and grade extension work, enabling rapid adaptation to emergent application environments or updated regulatory scenarios.
The manufacturing team manages lot traceability and complaint handling through an integrated quality system. Release criteria specify more than simple content analysis, extending to appearance, odor, and packaging integrity, with thresholds determined by both internal standards and individual customer supply agreements. End-user complaints relating to preservation drift, unexpected discoloration, or odor complaints prompt root cause investigations at batch and process unit operation level. Corrective actions may include process recalibration, re-qualification of supply chain inputs, or revision to packing/storage protocols. Ongoing customer support includes timely provision of batch-specific data, revision histories for product grades, and rationale documentation for any process or specification changes affecting delivered MIT.
Operating as a manufacturer of 2-Methyl-4-Isothiazolin-3-One (MIT) means running the entire process—raw material sourcing, continuous production, and batch release—under one roof. We oversee every step, from synthesis to purification, using established reaction routes and in-house process controls. Direct oversight at this scale guarantees that each batch meets color, purity, and concentration targets necessary for regulatory and technical compliance in industrial sectors.
MIT functions as a broad-spectrum preservative in a range of water-based formulations. Facilities producing paints, adhesives, and paper coatings rely on MIT for microbial control. Water treatment operations and specialty chemical formulations also depend on MIT for its biocidal effectiveness at low concentrations. Because many applications demand a stable and consistent active, manufacturers and formulators require predictable product integrity not only for performance, but also for downstream processing and warranty demands.
A factory that manages its own MIT production line can implement inline monitoring and tightly specified raw input testing. We invest in dedicated analytical equipment including high-performance liquid chromatography and spectrophotometry, running validation checks at multiple stages for each batch. This tight loop guarantees that each container leaving our facility matches technical expectations, which reduces variances in the customer’s end process—especially important during scale-up or regulatory audits.
Industrial buyers require MIT shipped in a range of packaging formats. We fill and seal MIT in drums, IBCs, or custom containers directly on-site, minimizing cross-contamination and exposure risks. Our packing lines operate alongside our reactors, which shortens the lead time from production to shipment. Close proximity between production and packing lines enables faster order fulfillment and supports urgent supply requirements during plant turnarounds or seasonal demand spikes.
Factories working with MIT often ask for more than bulk material delivery. Customers bring in our technical staff for compatibility guidance with pH adjusters, dispersants, or in-line process variables. We assist with methods for dilution, blending advice, and best practice integration with other microbicides to extend efficacy windows. With practical experience from our daily production cycles, our technical staff can respond to formulation intricacies encountered during upscaling or regulatory submissions.
Direct engagement with a manufacturer streamlines the supply chain and reduces risk exposure for manufacturers, distributors, and procurement teams. Continuous, plant-level production oversight shortens the response time for specification queries or compliance documentation. Large volume buyers gain the security of consistent batch quality without mixed-lot shipments or delays tied to third-party aggregation. Procurement teams can work from clear batch histories and regular supply planning discussions, supporting more stable production planning and cost management downstream.
Producing 2-Methyl-4-Isothiazolin-3-One within our own facilities provides control, transparency, and reliability that meet the high demands of industrial customers. Whether the end use is in coatings, water treatment, adhesives, or specialty applications, this approach ensures that both technical and business operations run with fewer surprises and more predictable outcomes.
Decades in specialty chemicals have taught us that antimicrobial preservation is as much about the matrix as it is about the molecule. 2-Methyl-4-Isothiazolin-3-One, or MIT, deserves a close look—especially when surfactant systems are involved. Our own experience with formulating MIT in different surfactant blends has shown that the chemical environment does not just influence shelf life, but it also affects overall performance and regulatory compliance.
In our large-scale R&D batches, we’ve worked with a broad selection of non-ionic, anionic, and amphoteric surfactants. Non-ionic systems, such as alkyl polyglucosides, generally support MIT stability well. We see less degradation and limited impact on preservation activity, even at processing temperatures between 25°C and 40°C.
With harsh anionics—think sodium lauryl ether sulfates—it gets trickier. MIT can undergo slower decomposition due to their nucleophilic tendencies, particularly above pH 8. We have monitored pH drift closely, using our own inline controls during compounding. Cases of loss of MIT actives happen faster if the pH is not corrected. This has led us to recommend a target pH window of 4 to 8 for best results, with ongoing monitoring to avoid unplanned drift during storage.
Amphoteric surfactant systems, such as cocamidopropyl betaine, often present fewer compatibility issues. In our own formulations, MIT consistently remains effective even after repeated heat-cool cycles. Still, excessive nitrogen content or aggressive buffer salts raise the risk of MIT loss during prolonged storage. We address this by controlling additive concentrations during our batching process.
Direct feedback from our technical team has highlighted a few recurring challenges. Chelators and certain stabilizers—especially EDTA or protein residues—may accelerate MIT breakdown. In personal care and home cleaning systems, repeated compatibility issues traced back to strong chelation or incompatible fragrance packages. Our solution is to screen raw materials in new batches, running real-time stability studies to flag unwanted reactions.
We utilize flash chromatography and spectrophotometry to track MIT content across product aging cycles. Our lab can adjust input concentrations based on observed decay rates. This hands-on approach supports large-volume customers who operate in markets where MIT’s legal usage levels are under close scrutiny.
We manufacture MIT to strict purity standards that help maintain stability from our drums to your mixing vessels. Accelerated aging tests in our own climate chambers routinely reach 12 months and beyond, even in complex surfactant bases. For concentrated formulations with aggressive surfactants or high pH, we sometimes recommend buffered dilutions to minimize the loss of preservative activity.
Whenever our technical staff encounters a new surfactant blend, we conduct full compatibility panels—testing for color changes, phase separation, or any unexpected odor development. We communicate these findings directly, as we have found end-use performance varies most where blends push pH or involve poorly defined raw material inputs.
Managing MIT in large liquid batches means more than running textbook reactions; it takes ongoing process control and transparent QA. From raw material sourcing to shipment, we record every variable. When our QA identifies unwanted MIT loss, we share corrective steps—ranging from pH adjustment to alternate surfactant selection—to get the balance right.
We stand behind MIT’s value as a preservative, but we recognize that careful surfactant selection and batch testing offer the most reliable path to stable, regulatory-compliant products. Our factories run routine compatibility screening and offer technical support, so customers do not have to rely on guesswork. Through years of hands-on development and bulk production, we have learned that realism—backed by hard data and production experience—delivers the most robust solutions for MIT application in surfactant systems.
At our manufacturing plant, we focus on supplying 2-Methyl-4-Isothiazolin-3-One (MIT) with consistency and reliability directly from our production line. Each batch meets industry standards for purity and performance required by formulators in industrial, institutional, and consumer product applications. As a direct manufacturer, our standard minimum order quantity is set to balance logistics and production scale against customer demand. Currently, for MIT, the minimum order sits at 500 kilograms per shipment. This quantity enables us to optimize packaging and shipping efficiencies while keeping our lot testing and production runs strictly controlled.
Our MOQ policy is based on years of operational experience. We run large-scale synthesis batches of MIT to control costs and maintain tight batch-to-batch consistency. When smaller orders are filled, we face increased process interruptions, higher changeover costs, and more challenging logistics planning on our end. By setting MOQ at an industrially practical level, we offer customers more stable pricing and faster lead times on repeat orders without compromising quality. Small volumes drive up unit costs, but at our minimum the economies of scale come into play and all customers benefit from factory-direct pricing.
We support a progressive bulk discount structure for qualified orders on MIT. Our team reviews demand schedules, delivery locations, and annual volume forecasts to craft a discount plan for high-volume customers. Typical tiers start at 2 metric tons per shipment, with further price incentives applied above 5 metric tons per release. As production planners, we are happy to collaborate with procurement teams to time shipments and scheduling for greater cost efficiencies. The goal is always direct savings passed from our factory floor to our customer, without hidden markups or supply chain uncertainty.
By working directly with the producer, customers access not only timely shipments from our bulk storage facilities but also technical documentation that reflects firsthand manufacturing controls. We advise users on best practices for storage, blending, and safety right from our plant experience. Our technical specialists are available to provide detailed test reports, sample documentation, and regulatory support on MIT with no delay or third-party confusion.
We offer MIT in standard industrial drums, IBCs, and tank trucks to suit customer handling systems. Orders placed above MOQ receive priority production status and optimized freight solutions. Our logistics team maintains strong transport partnerships so that even large shipments transition smoothly from our factory to your site, with clear documentation and rigorous safety handling.
As the manufacturer, we take responsibility for quality, supply reliability, and transparency across our business relationships. We understand the impact of raw material disruptions and our MOQ and bulk discount policies are structured to avoid such outcomes. Our focus stays on supporting our long-term partners with stable supply and ongoing product and technical guidance.
Over years in the specialty chemicals sector, we have found that transporting 2-Methyl-4-Isothiazolin-3-One (MIT) across borders raises more than a paperwork issue. MIT carries a distinct hazard profile, flagged for its potential health and environmental impacts. Regulatory control for MIT falls under several global frameworks, including the UN’s Recommendations on the Transport of Dangerous Goods, as well as country- or region-specific rules such as the European ADR and IMDG code for sea freight. Our technical and regulatory departments keep close watch on the shifting classifications, as even minor changes can impact labeling, shipping mode, and declaration requirements.
We only fill MIT into containers rigorously tested for chemical compatibility and mechanical strength. Packaging integrity is not a box-checking exercise; it directly reflects our commitment to product stewardship. UN-certified drums or IBCs labeled for hazardous liquids get selected due to their proven performance during rough handling and temperature swings en route. Our teams monitor filling, sealing, and batch coding to eliminate the risks of leakage, contamination, or misidentification. Only properly labeled goods, highlighting hazard class and UN number, leave our facilities.
Documentation mistakes can delay clearance or, in the worst-case, halt cargo. Our approach roots itself in certainty—each MIT shipment moves with a full set of transport documents, including Safety Data Sheets (SDS) tailored to destination language, the correct Dangerous Goods Declaration, and a compliant commercial invoice. We keep the SDS up-to-date with global harmonized systems, reflecting hazard categories and first-aid advice aligning with local laws. Our shipping paperwork includes complete details for Customs, port, and carrier review, with consistent batch traceability enabling any necessary recalls or regulatory communications.
With MIT’s hazard status, options such as air freight typically require enhanced packaging and more detailed documentation. Sea shipments demand that every container on the manifest accurately lists dangerous goods status. Land transportation, especially within North America and Europe, brings further restrictions concerning driver training and vehicle labeling. Our logistics planners review regulations for every route and carrier, using prior shipment experience and up-to-date regulatory advice to avoid accidental violations that can cause shipment delays.
Shipping rules for MIT seldom remain static. Proposed reclassifications, stricter environmental regulations, or tighter restrictions on biocides can alter the landscape overnight. From our vantage point as a manufacturer, we invest in periodic regulatory training for staff and monitor new guidance and case law. This vigilance minimizes interruption for downstream users and prevents compliance surprises. Our customers see the benefit in fewer delays, complete traceability, and reliable delivery dates.
Direct control over production gives us the advantage of providing not just documentation, but assurance that every shipment matches its stated quality, purity, and hazard categorization. Our technical support team can supply regulatory and technical dossiers on demand, advising on compliant usage and end-user handling. This full-circle accountability reduces risk and empowers customers to focus on their own processes instead of worrying about gaps in the supply chain.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
